EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections

Maria Tsilika iD, Fotinie Ntziora iD, Efthymia Giannitsioti iD

Pathogens · 01.02.2025 · 14 (2) · 130

DOI: 10.3390/pathogens14020130 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 01.02.2025. Verfasst von Maria Tsilika und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Gram-Negative Bacteria, Gram-Negative Bacterial Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug (MDR) and extensive drug (XDR) resistance in Gram-negative bacteria (GNB) emerges worldwide. Although bone and joint infections are mostly caused by Gram-positive bacteria, mainly Staphylococci, MDR GNB substantially increase also as a complication of hospitalization and previous antibiotic administration. This narrative review analyzes the epidemiological trend, current experimental data, and clinical experience with available therapeutic options for the difficult to treat (DTR) GNB implicated in bone and joint infections with or without orthopedic implants. The radical debridement and removal of the implant is adequate therapy for most cases, along with prompt and prolonged combined antimicrobial treatment by older and novel antibiotics. Current research and clinical data suggest that fluoroquinolones well penetrate bone tissue and are associated with improved outcomes in DTR GNB; if not available, carbapenems can be used in cases of MDR GNB. For XDR GNB, colistin, fosfomycin, tigecycline, and novel β-lactam/β-lactamase inhibitors can be initiated as combination schemas in intravenous administration, along with local elution from impregnated spacers. However, current data are scarce and large multicenter studies are mandatory in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, Multiple, BacterialGram-Negative BacteriaGram-Negative Bacterial InfectionsAnti-Bacterial AgentsHumans

Stichwörter der Autor:innen

Gram-negative bacteriaantibioticsbone and joint infectionsmultidrug resistant

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • 1st Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.
  • 1st Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece.

ORCID-Profile: Maria Tsilika, Fotinie Ntziora, Efthymia Giannitsioti

Zitieren

APA

Tsilika, M., Ntziora, F., & Giannitsioti, E. (2025). Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections. Pathogens, 14(2), 130. https://doi.org/10.3390/pathogens14020130

Vancouver

Tsilika M, Ntziora F, Giannitsioti E. Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections. Pathogens. 2025;14(2):130. doi:10.3390/pathogens14020130

BibTeX
@article{Tsilika2025,
  author = {Tsilika, Maria and Ntziora, Fotinie and Giannitsioti, Efthymia},
  title = {Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {130},
  doi = {10.3390/pathogens14020130}
}
Kostenlos starten →